CAUWENBERGH GEERT 4
4 · Phio Pharmaceuticals Corp. · Filed Mar 3, 2021
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2021-03-01+10,000→ 22,822 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.
- [F2]Includes shares of common stock underlying unvested restricted stock units. Effective as of 12:01 a.m. Eastern Time on January 15, 2020, the issuer effected a reverse split of its outstanding shares of common stock at a ratio of 1-for-55.